Cargando…
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
The “Thalidomide tragedy” is a landmark in the history of the pharmaceutical industry. Despite limited clinical trials, there is a continuous effort to investigate thalidomide as a drug for cancer and inflammatory diseases such as rheumatoid arthritis, lepromatous leprosy, and COVID-19. This review...
Autores principales: | Dsouza, Nikitha Naomi, Alampady, Varun, Baby, Krishnaprasad, Maity, Swastika, Byregowda, Bharath Harohalli, Nayak, Yogendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039777/ https://www.ncbi.nlm.nih.gov/pubmed/36966238 http://dx.doi.org/10.1007/s10787-023-01193-1 |
Ejemplares similares
-
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020) -
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
por: Baby, Krishnaprasad, et al.
Publicado: (2023) -
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
por: Maity, Swastika, et al.
Publicado: (2020)